Ligand-free mitochondria-localized mutant AR-induced cytotoxicity in spinal bulbar muscular atrophy
Open Access
- 22 July 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 146 (1) , 278-294
Abstract
Spinal bulbar muscular atrophy (SBMA), the first identified CAG-repeat expansion disorder, is an X-linked neuromuscular disorder involving CAG-repeat-expansion mutations in the androgen receptor (AR) gene. We utilized CRISPR-Cas9 gene editing to engineer novel isogenic human induced pluripotent stem cell (hiPSC) models, consisting of isogenic AR knockout, control and disease lines expressing mutant AR with distinct repeat lengths, as well as control and disease lines expressing FLAG-tagged wild-type and mutant AR, respectively. Adapting a small-molecule cocktail-directed approach, we differentiate the isogenic hiPSC models into motor neuron-like cells with a highly enriched population to uncover cell-type-specific mechanisms underlying SBMA and to distinguish gain- from loss-of-function properties of mutant AR in disease motor neurons. We demonstrate that ligand-free mutant AR causes drastic mitochondrial dysfunction in neurites of differentiated disease motor neurons due to gain-of-function mechanisms and such cytotoxicity can be amplified upon ligand (androgens) treatment. We further show that aberrant interaction between ligand-free, mitochondria-localized mutant AR and F-ATP synthase is associated with compromised mitochondrial respiration and multiple other mitochondrial impairments. These findings counter the established notion that androgens are requisite for mutant AR-induced cytotoxicity in SBMA, reveal a compelling mechanistic link between ligand-free mutant AR, F-ATP synthase and mitochondrial dysfunction, and provide innovative insights into motor neuron-specific therapeutic interventions for SBMA.Keywords
Funding Information
- NINDS Competitive Postdoctoral Fellowship Award
- Kennedy’s Disease Association Research Grant
- Maryland Stem Cell Research Fund Launch Award
- Intramural Research Program of the NINDS
- National Institutes of Health
This publication has 42 references indexed in Scilit:
- Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator systemCell Research, 2013
- RNA toxicity in polyglutamine disorders: concepts, models, and progress of researchJournal of Molecular Medicine, 2013
- Mechanisms Mediating Spinal and Bulbar Muscular Atrophy: Investigations into Polyglutamine-Expanded Androgen Receptor Function and DysfunctionFrontiers in Neurology, 2013
- Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)Progress in Neurobiology, 2012
- Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trialThe Lancet Neurology, 2011
- Differential vulnerability of neurons in Huntington’s disease: the role of cell type‐specific featuresJournal of Neurochemistry, 2010
- Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophyHuman Molecular Genetics, 2009
- Androgen Receptor Functional Analyses by High Throughput Imaging: Determination of Ligand, Cell Cycle, and Mutation-Specific EffectsPLOS ONE, 2008
- Mitochondrial abnormalities in spinal and bulbar muscular atrophyHuman Molecular Genetics, 2008
- Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patientsBrain, 2006